Edition:
United States

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,231.00GBp
9:41am EDT
Change (% chg)

24.00 (+0.57%)
Prev Close
4,207.00
Open
4,190.00
Day's High
4,239.00
Day's Low
4,190.00
Volume
1,777,692
Avg. Vol
4,083,125
52-wk High
4,894.00
52-wk Low
2,940.50

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.47
Market Cap(Mil.): £38,496.78
Shares Outstanding(Mil.): 913.89
Dividend: 21.46
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 25.07 28.56 32.59
EPS (TTM): 1.68 -- --
ROI: 3.43 13.05 12.60
ROE: 6.14 14.79 14.49

UPDATE 2-Takeda sees lower annual profit, generics to erode cancer drug sales

* Takeda looking to strengthen pipeline by acquiring Shire (Adds executive comment, details)

May 14 2018

Britain's IWG receives takeover approaches from three suitors

LONDON British serviced office provider IWG has attracted takeover approaches from three rival suitors, potentially plunging the $3.1 billion company into a bidding war.

May 11 2018

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry. | Video

May 09 2018

Breakingviews - Takeda swallows big dose of risk to buy Shire

LONDON (Reuters Breakingviews) - Takeda Pharmaceutical is swallowing a big dose of risk to buy Shire. The Japanese drugmaker finally struck a deal to take control of its Irish peer, for $62 billion. It can just about make the math work, but requires big spending cuts and a load of debt.

May 08 2018

UPDATE 5-Japan's Takeda clinches $62 bln Shire deal as pharma M&A rolls on

* Deal expected to close in first half of 2019 (Adds ratings agency reaction, further details)

May 08 2018

FTSE helped by weaker pound; Shire, Virgin get takeover boost

MILAN, May 8 The FTSE edged up on Tuesday after a long weekend as a drop in the pound supported the internationally exposed index, while takeover activity boosted shares in drug-maker Shire and Virgin Money bank.

May 08 2018

REFILE-Japan's Takeda agrees $62 billion takeover of Shire

LONDON, May 8 Takeda Pharma agreed to buy London-listed Shire for 46 billion pounds ($62.42 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.

May 08 2018

Dollar near three-month highs against euro

NEW YORK Weaker-than-expected German data hurt the euro against the U.S. dollar on Monday, with investors further unwinding short positions on the greenback that were based on assumptions that the European Central Bank was nearer to unwinding its stimulus.

Apr 30 2018

Dollar near three-month highs against euro

NEW YORK Weaker-than-expected German data hurt the euro against the U.S. dollar on Monday, with investors further unwinding short positions on the greenback that were based on assumptions that the European Central Bank was nearer to unwinding its stimulus.

Apr 30 2018

FOREX-Dollar below 3-month highs as U.S. 10-year yield pulls back

* Fed policy meeting, U.S. jobs data coming up this week (Updates prices)

Apr 30 2018

Earnings vs. Estimates